Registration Frequencies

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 974 51
Brodalumab 189 0
Certolizumab 49 0
Efalizumab 35 0
Etanercept 304 49
Golimumab 26 0
Guselkumab 347 0
Infliximab 101 1
Ixekizumab 297 0
Secukinumab 1065 0
Tildrakizumab 83 0
Ustekinumab 664 0
Apremilast 409 0
Ciclosporin 371 0
Fumaderm 2548 0
Skilarence 1098 0
Methotrexate 2687 0
other systemics 434 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers